Fulgent Genetics, Inc. FLGT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Laboratory Services | $71.05M-3.3% | $83.03M+8.9% | $83.93M+17.0% | $81.8M+15.2% | $73.46M+13.9% | |
| Therapeutic Development | $87K— | $309K— | $138K— | $0— | $0— | |
| Revenue by Geography | ||||||
| Non Us | $6.03M+7.0% | $8.43M+37.3% | $6.46M+7.0% | $5.6M-18.1% | $5.64M-15.0% | |
| Other Countries | $3.47M+14.8% | $3.67M+28.1% | $3.33M+2.4% | $3.19M-26.8% | $3.03M+19.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Fulgent Genetics, Inc. break its business down?
- Fulgent Genetics, Inc. (FLGT) reports revenue by business across 2 parts — Laboratory Services and Therapeutic Development. Each is extracted from the segment footnotes and tracked over time.
- Where does Fulgent Genetics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Fulgent Genetics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
